Medtronic Inc
(MDT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 04/30
| 04-2020 | 04-2019 | 04-2018 | 04-2017 | 04-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 4,806,000 | 4,650,000 | 3,095,000 | 4,024,000 | 3,538,000 |
| Depreciation Amortization | 2,663,000 | 2,659,000 | 2,644,000 | 2,917,000 | 2,849,000 |
| Income taxes - deferred | -1,315,000 | -304,000 | -919,000 | -459,000 | -460,000 |
| Accounts receivable | 1,291,000 | -581,000 | -275,000 | -75,000 | -435,000 |
| Other Working Capital | 61,000 | -1,080,000 | -173,000 | 139,000 | -1,403,000 |
| Other Operating Activity | -272,000 | 1,663,000 | 312,000 | 334,000 | 1,129,000 |
| Operating Cash Flow | $7,234,000 | $7,007,000 | $4,684,000 | $6,880,000 | $5,218,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -1,465,000 | 2,151,000 | 1,027,000 | 985,000 | 4,518,000 |
| PPE Investments | -1,213,000 | -1,134,000 | -1,068,000 | -1,254,000 | -1,046,000 |
| Net Acquisitions | -488,000 | -1,827,000 | 5,921,000 | -1,324,000 | -1,213,000 |
| Other Investing Activity | -37,000 | 36,000 | -22,000 | 22,000 | -14,000 |
| Investing Cash Flow | $-3,203,000 | $-774,000 | $5,858,000 | $-1,571,000 | $2,245,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -17,000 | -713,000 | -249,000 | 906,000 | 146,000 |
| Debt Issued | 5,568,000 | 7,794,000 | 21,000 | 2,140,000 | 0 |
| Debt Repayment | -6,110,000 | -7,948,000 | -7,370,000 | -863,000 | -5,132,000 |
| Common Stock Issued | 662,000 | 992,000 | 403,000 | 428,000 | 491,000 |
| Common Stock Repurchased | -1,326,000 | -2,877,000 | -2,171,000 | -3,544,000 | -2,830,000 |
| Dividend Paid | -2,894,000 | -2,693,000 | -2,494,000 | -2,376,000 | -2,139,000 |
| Other Financing Activity | -81,000 | 14,000 | -94,000 | 26,000 | -79,000 |
| Financing Cash Flow | $-4,198,000 | $-5,431,000 | $-11,954,000 | $-3,283,000 | $-9,543,000 |
| Exchange Rate Effect | -86,000 | -78,000 | 114,000 | 65,000 | 113,000 |
| Beginning Cash Position | 4,393,000 | 3,669,000 | 4,967,000 | 2,876,000 | 4,843,000 |
| End Cash Position | 4,140,000 | 4,393,000 | 3,669,000 | 4,967,000 | 2,876,000 |
| Net Cash Flow | $-253,000 | $724,000 | $-1,298,000 | $2,091,000 | $-1,967,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 7,234,000 | 7,007,000 | 4,684,000 | 6,880,000 | 5,218,000 |
| Capital Expenditure | -1,213,000 | -1,134,000 | -1,068,000 | -1,254,000 | -1,046,000 |
| Free Cash Flow | 6,021,000 | 5,873,000 | 3,616,000 | 5,626,000 | 4,172,000 |